Anika Therapuetics
Print

Fast Facts About Anika Therapeutics, Inc.

President & CEO:

Charles H. Sherwood, Ph.D.

Founded:

1993

Employees:

129 as of December 31, 2011

Headquarters:

Bedford, MA

Exchange and Symbol:

NASDAQ Global Select Market ® under the symbol: ANIK

Areas of Focus:


Orthobiologics
Relief of pain due to osteoarthritis; protection of soft tissues; and repair/regeneration of cartilage damage and defects

Dermal
Advanced wound care solutions and skin substitutes; and dermal fillers to reduce wrinkles

Ophthalmic
Viscoelastic used in intraocular surgery

Veterinary
Relief of pain due to osteoarthritis

Anti-Adhesion
Post-operative adhesion barriers and healing agents used in spinal, abdominal, and ear, nose and throat ("ENT") surgical procedures

Top Products:

Product Name
Disease/Condition
Orthovisc®
Osteoarthritis
Merogel®
Post-operative ENT procedure healing   
Hyalograft® C Autograft
Cartilage regeneration
Hyalofast®
Cartilage regeneration
Hyalomatrix®
Wound healing
Hyalobarrier®
Post-operative adhesion barrier for abdominal indications
Hyvisc®
Equine osteoarthritis
Hyaloglide®
Post-operative adhesion barrier for hand surgery

Key Pipeline Products:

Product Name
Disease/Condition
Monovisc®
Osteoarthritis, pending U.S. PMA approval, and approved in Europe
Cingal
Osteoarthritis, pre-clinical development
Hyalobone
Bone tissue filler
Hyalospine
Adhesion prevention post spinal surgery